MeiraGTx Holdings (MGTX) Other Accumulated Expenses (2017 - 2025)

MeiraGTx Holdings (MGTX) posted Other Accumulated Expenses of $2.6 million for Q4 2025, down 90.69% on a QoQ basis from $28.2 million in Q3 2025, and up 191.25% year-over-year from $903000.0 in Q4 2024.

MeiraGTx Holdings (MGTX) Other Accumulated Expenses (2017 - 2025) Analysis & Trends

MeiraGTx Holdings' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $2.6 million for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 191.25% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (up 191.25% YoY) and the FY2025 annual result came in at $2.6 million, up 191.25% from the prior year.
  • Other Accumulated Expenses was $2.6 million for Q4 2025 at MeiraGTx Holdings, down from $28.2 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $28.2 million in Q3 2025 and bottomed at $134000.0 in Q2 2021.
  • A 5-year average of $2.1 million and a median of $449000.0 in 2021 frame the typical range for Other Accumulated Expenses.
  • Peak annual rise in Other Accumulated Expenses reached 5783.54% in 2025, while the deepest fall reached 84.71% in 2025.
  • MeiraGTx Holdings' Other Accumulated Expenses stood at $456000.0 in 2021, then jumped by 104.39% to $932000.0 in 2022, then soared by 37.12% to $1.3 million in 2023, then fell by 29.34% to $903000.0 in 2024, then soared by 191.25% to $2.6 million in 2025.
  • Business Quant data shows MGTX's Other Accumulated Expenses at $2.6 million in Q4 2025, $28.2 million in Q3 2025, and $160000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.84 Bn 467.05 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 MeiraGTx Holdings 997.33 Mn 931.40 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.63 Mn
Sep 30, 2025 28.24 Mn
Jun 30, 2025 160,000.00
Mar 31, 2025 154,000.00
Dec 31, 2024 903,000.00
Sep 30, 2024 480,000.00
Jun 30, 2024 136,000.00
Mar 31, 2024 1.01 Mn
Dec 31, 2023 1.28 Mn
Sep 30, 2023 2.48 Mn
Jun 30, 2023 260,000.00
Mar 31, 2023 321,000.00
Dec 31, 2022 932,000.00
Sep 30, 2022 400,000.00
Jun 30, 2022 983,000.00
Mar 31, 2022 354,000.00
Dec 31, 2021 456,000.00
Sep 30, 2021 328,000.00
Jun 30, 2021 134,000.00
Mar 31, 2021 442,000.00